Ipragliflozin |
(1S)-1,5-Anhydro-1-C-[3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl]-D-glucitol |
(CAS 761423-87-4) |
 |
Description: |
Ipragliflozin (ASP1941) is a highly potent and selective SGLT2 inhibitor with IC50 of 2.8 nM; little and NO potency for SGLT1/3/4/5/6.
IC50 value: 2.8 nM
Target: SGLT2
in vitro: Ipragliflozin potently and selectively inhibited human, rat, and mouse SGLT2 at nanomolar ranges and exhibited stability against intestinal glucosidases.
in vivo: Ipragliflozin showed good pharmacokinetic properties following oral dosing, and dose-dependently increased urinary glucose excretion, which lasted for over 12 h in normal mice. Oral administration of ipragliflozin increased urinary glucose excretion in a dose-dependent manner, an effect which was significant at doses of 0.3 mg/kg or higher and lasted over 12 h. Single administration of ipragliflozin dose-dependently increased urinary glucose excretion, reduced blood glucose and plasma insulin levels, and improved glucose intolerance.
|
Product No. |
KT20205 |
Product Name |
Ipragliflozin |
Synonyms |
ASP1941; ASP 1941; ASP-1941 |
Formal Name |
(1S)-1,5-Anhydro-1-C-[3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl]-D-glucitol |
CAS Number |
761423-87-4 |
Molecular Formula |
C21H21FO5S |
Formula Weight |
404.45 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
SGLT2 inhibitor
Canagliflozin
Canagliflozin hemihydrate
Dapagliflozin
Dapagliflozin(2S)-1,2-propanediol,hydrate
Empagliflozin
LX-4211
PF-04971729
Phloretin
Phlorizin
|
|